The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network). These functions are accomplished through its interactions with key research entities (IRB, Pharmaceutical Research Center and Disease Oriented Working Groups/Clinical Research Groups) and the clinical care entities (Clinical Research Unit, UW Hospital and Clinics). The CRCO also provides essential administrative support to UWCCC clinical research committees such as the Protocol Review and Monitoring Committee and Data Safety and Monitoring Committee. The CRCO staff members provide the following services;? Protocol review and implementation, which includes protocol identification, protocol review, protocol activation, study closure, and database management ? Human subjects committee coordination and oversight, which includes protocol activation and continuing annual review tracking ? Centralized patient tracking ? Research policy development, coordination and implementation, which is developed and implemented through the Program Manager Committee and the development of standard operating procedures ? Training coordination and implementation ? Education and corrective action facilitation ? Administrative oversight ? Protocol development and patient case report forms development for Investigator Initiated Trials ? Data abstraction and final report tables for Investigator Initiated Trials The Faculty Leader for the CRCO is the Associate Director for Clinical Research (Brad Kahl, M.D.), who has extensive experience in the conduct and oversight of clinical research.

Public Health Relevance

The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-40
Application #
8762775
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
40
Fiscal Year
2014
Total Cost
$168,602
Indirect Cost
$59,442
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Oberley, Christopher C; Bilger, Andrea; Drinkwater, Norman R (2015) Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis. Mol Carcinog 54:959-70
Wisinski, Kari B; Ledesma, Wendy M; Kolesar, Jill et al. (2015) A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1?,24(S)Dihydroxyvitamin D2) in patients with advanced cancer. J Oncol Pharm Pract 21:416-24
Kolesar, Jill M; Pomplun, Marcia; Havighurst, Tom et al. (2015) Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer. J Oncol Pharm Pract 21:128-31
Simoncic, Urban; Perlman, Scott; Liu, Glenn et al. (2015) Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases. Clin Genitourin Cancer 13:e7-e17
Zhao, Z; Wang, L; Xu, W (2015) IL-13R?2 mediates PNR-induced migration and metastasis in ER?-negative breast cancer. Oncogene 34:1596-607
Chakravarty, Rubel; Hong, Hao; Cai, Weibo (2015) Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature. Curr Drug Targets 16:592-609
Wu, Jianqiang; Salva, Katrin A; Wood, Gary S (2015) c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death. J Invest Dermatol 135:861-8
LoConte, Noelle K; Razak, Albiruni R A; Ivy, Percy et al. (2015) A multicenter phase 1 study of ? -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs 33:169-76
Romens, Sarah E; McDonald, Jennifer; Svaren, John et al. (2015) Associations between early life stress and gene methylation in children. Child Dev 86:303-9
Nihal, Minakshi; Ahmad, Nihal; Wood, Gary S (2014) SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle 13:632-40

Showing the most recent 10 out of 472 publications